Expansion20 Jan 2026, 03:37 pm
SRF Ltd Approves Capital Expenditure for New Pharma Intermediate Plant
AI Summary
SRF Ltd, in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, has approved a project for setting up a New Pharma Intermediate Plant (PIP-2) at a projected cost of Rs. 180 Crores at Dahej, Gujarat. The new plant will undertake precursor processes for the production of Pharma products. The investment will be financed through a mix of debt and internal accruals. The rationale behind this decision is to tap new and upcoming business opportunities in the pharma sector.
Key Highlights
- SRF Ltd approves project for New Pharma Intermediate Plant (PIP-2)
- Project cost estimated at Rs. 180 Crores
- Plant to be set up at Dahej, Gujarat
- Financing through mix of debt and internal accruals
- Move aimed at tapping new business opportunities in the pharma sector